Exon architecture controls mRNA m <sup>6</sup> A suppression and gene expression

P. Cody He(Howard Hughes Medical Institute), Jiangbo Wei(Howard Hughes Medical Institute), Xiaoyang Dou(Howard Hughes Medical Institute), Bryan T. Harada(Howard Hughes Medical Institute), Zijie Zhang(Howard Hughes Medical Institute), Ruiqi Ge(Howard Hughes Medical Institute), Chang Liu(Howard Hughes Medical Institute), Lisheng Zhang(Howard Hughes Medical Institute), Xianbin Yu(Howard Hughes Medical Institute), Shuai Wang(University of Chicago), Ruitu Lyu(Howard Hughes Medical Institute), Zhongyu Zou(Howard Hughes Medical Institute), Mengjie Chen(University of Chicago), Chuan He(Howard Hughes Medical Institute)
Science
January 27, 2023
Cited by 242Open Access
Full Text

Abstract

N 6 -methyladenosine (m 6 A) is the most abundant messenger RNA (mRNA) modification and plays crucial roles in diverse physiological processes. Using a massively parallel assay for m 6 A (MPm 6 A), we discover that m 6 A specificity is globally regulated by suppressors that prevent m 6 A deposition in unmethylated transcriptome regions. We identify exon junction complexes (EJCs) as m 6 A suppressors that protect exon junction–proximal RNA within coding sequences from methylation and regulate mRNA stability through m 6 A suppression. EJC suppression of m 6 A underlies multiple global characteristics of mRNA m 6 A specificity, with the local range of EJC protection sufficient to suppress m 6 A deposition in average-length internal exons but not in long internal and terminal exons. EJC-suppressed methylation sites colocalize with EJC-suppressed splice sites, which suggests that exon architecture broadly determines local mRNA accessibility to regulatory complexes.


Related Papers

No related papers found

Powered by citation graph analysis